Cita APA (7a ed.)
Ogasawara, A., Kiefer, J. R., Gill, H., Chiang, E., Sriraman, S., Ferl, G. Z., . . . Boswell, C. A. (2023). Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy. European Journal of Nuclear Medicine & Molecular Imaging, 50(2), 287-302.
Cita Chicago Style (17a ed.)
Ogasawara, Annie, et al. "Preclinical Development of ZED8, an 89Zr Immuno-PET Reagent for Monitoring Tumor CD8 Status in Patients Undergoing Cancer Immunotherapy." European Journal of Nuclear Medicine & Molecular Imaging 50, no. 2 (2023): 287-302.
Cita MLA (9a ed.)
Ogasawara, Annie, et al. "Preclinical Development of ZED8, an 89Zr Immuno-PET Reagent for Monitoring Tumor CD8 Status in Patients Undergoing Cancer Immunotherapy." European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 2, 2023, pp. 287-302.
Precaución: Estas citas no son 100% exactas.